MX2007009985A - Diastereoisomeros de 4-hidroxiisoleucina y usos de los mismos. - Google Patents
Diastereoisomeros de 4-hidroxiisoleucina y usos de los mismos.Info
- Publication number
- MX2007009985A MX2007009985A MX2007009985A MX2007009985A MX2007009985A MX 2007009985 A MX2007009985 A MX 2007009985A MX 2007009985 A MX2007009985 A MX 2007009985A MX 2007009985 A MX2007009985 A MX 2007009985A MX 2007009985 A MX2007009985 A MX 2007009985A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxyisoleucine
- diabetes
- type
- isomers
- diastereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65441305P | 2005-02-18 | 2005-02-18 | |
| PCT/IB2006/001758 WO2006117696A2 (en) | 2005-02-18 | 2006-02-17 | Diastereoisomers of 4-hydroxyisoleucine and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007009985A true MX2007009985A (es) | 2008-03-11 |
Family
ID=37086084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007009985A MX2007009985A (es) | 2005-02-18 | 2006-02-17 | Diastereoisomeros de 4-hidroxiisoleucina y usos de los mismos. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1853552A2 (ja) |
| JP (1) | JP2008530198A (ja) |
| CN (1) | CN101128418A (ja) |
| AU (1) | AU2006242851A1 (ja) |
| BR (1) | BRPI0607140A2 (ja) |
| CA (1) | CA2598491A1 (ja) |
| MX (1) | MX2007009985A (ja) |
| WO (1) | WO2006117696A2 (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006131836A2 (en) * | 2005-03-22 | 2006-12-14 | Innodia Inc. | Compounds and compositions for use in the prevention and treatment of obesity and related syndromes |
| WO2008154743A1 (en) * | 2007-06-19 | 2008-12-24 | Innodia Inc. | Methods for the synthesis of 4-hydroxyisoleucine, stereoisomers and analogs thereof |
| US20110136911A1 (en) * | 2007-12-20 | 2011-06-09 | The Feinstein Institute For Medical Research | Treatment of sepsis and inhibition of mif by d-t4 |
| JP6800968B2 (ja) | 2015-10-23 | 2020-12-16 | ナビター ファーマシューティカルズ， インコーポレイテッド | セストリン−ｇａｔｏｒ２相互作用のモジュレーターおよびその使用 |
| JP7179015B2 (ja) | 2017-04-26 | 2022-11-28 | ナビター ファーマシューティカルズ， インコーポレイテッド | Ｓｅｓｔｒｉｎ－ＧＡＴＯＲ２相互座用のモジュレーターおよびその使用 |
| EP3870158A4 (en) | 2018-10-24 | 2022-08-10 | Navitor Pharmaceuticals, Inc. | POLYMORPHIC COMPOUNDS AND USES THEREOF |
| AU2020376950A1 (en) | 2019-11-01 | 2022-06-09 | Navitor Pharmaceuticals, Inc. | Methods of treatment using an mTORC1 modulator |
| CN112089710B (zh) * | 2020-08-07 | 2022-04-01 | 郑州大学 | 4-羟基异亮氨酸在制备抗肿瘤药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2797767B1 (fr) * | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
| BRPI0415781A (pt) * | 2003-10-27 | 2006-12-26 | Innodia Inc | método para o tratamento de diabetes em um paciente e kit farmacêutico |
| EP1657236A1 (en) * | 2004-11-10 | 2006-05-17 | Centre National De La Recherche Scientifique (Cnrs) | Method for preparing diastereoisomers of 4-hydroxy isoleucine |
-
2006
- 2006-02-17 AU AU2006242851A patent/AU2006242851A1/en not_active Abandoned
- 2006-02-17 BR BRPI0607140-6A patent/BRPI0607140A2/pt not_active Application Discontinuation
- 2006-02-17 JP JP2007555732A patent/JP2008530198A/ja active Pending
- 2006-02-17 MX MX2007009985A patent/MX2007009985A/es not_active Application Discontinuation
- 2006-02-17 EP EP06765601A patent/EP1853552A2/en not_active Withdrawn
- 2006-02-17 CA CA002598491A patent/CA2598491A1/en not_active Abandoned
- 2006-02-17 CN CNA2006800050682A patent/CN101128418A/zh active Pending
- 2006-02-17 WO PCT/IB2006/001758 patent/WO2006117696A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0607140A2 (pt) | 2009-08-11 |
| JP2008530198A (ja) | 2008-08-07 |
| WO2006117696A2 (en) | 2006-11-09 |
| CA2598491A1 (en) | 2006-11-09 |
| EP1853552A2 (en) | 2007-11-14 |
| AU2006242851A1 (en) | 2006-11-09 |
| WO2006117696A3 (en) | 2007-01-25 |
| CN101128418A (zh) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006120574A3 (en) | Analogs of 4-hydroxyisoleucine and uses thereof | |
| MX2007009985A (es) | Diastereoisomeros de 4-hidroxiisoleucina y usos de los mismos. | |
| WO2006002909A3 (en) | Sphingolipids against pathological processes in lipid rafts | |
| WO2007059372A3 (en) | Use of chloroquine to treat metabolic syndrome | |
| WO2006099941A8 (de) | Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| WO2007061661A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| MX2009003305A (es) | Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso. | |
| WO2009091576A3 (en) | Parenteral formulations of dopamine agonists | |
| WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
| TN2011000415A1 (en) | Pharmaceutical composition comprising a sglt2 inhibitor a dpp-i v inhibitor and optionally a further antidiabetic agent and uses thereof | |
| WO2008134828A8 (en) | Tissue degeneration protection | |
| UA100384C2 (en) | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative | |
| TW200738246A (en) | Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives | |
| WO2008055940A3 (en) | Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions | |
| CA2478237A1 (en) | Use of adapalene for the treatment of dermatological disorders | |
| MA30504B1 (fr) | Compositions pharmaceutiques stabilisees comprenant de la fesoterodine | |
| WO2006131836A3 (en) | Compounds and compositions for use in the prevention and treatment of obesity and related syndromes | |
| CY1108900T1 (el) | Πολυθειωμενα γλυκοζιδια και αλατα αυτων | |
| WO2007010281A3 (en) | Use of thiazole derivatives and analogues in disorders caused by free fatty acids | |
| WO2008022974A3 (fr) | Composition antidiabetique contenant de l'acide chicorique et/ou l'un de ses metabolites | |
| TW200706182A (en) | Combination immediate release controlled release levodopa and carbidopa dosage forms | |
| WO2007107008A8 (en) | Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity | |
| WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| EP2746254A3 (en) | Oxadiazole derivative active on sphingosine-1-phosphate (s1p) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |